|4Feb 27, 4:10 PM ET

Culwell Kelly 4

4 · Evofem Biosciences, Inc. · Filed Feb 27, 2019

Insider Transaction Report

Form 4
Period: 2019-02-25
Culwell Kelly
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-02-25+50,00061,985 total
Footnotes (1)
  • [F1]The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2019.

Documents

1 file
  • 4
    wf-form4_155130180168119.xmlPrimary

    FORM 4